Sentence Ordered in Drug Counterfeiting Case
Christopher Wayne Lamoreaux, 38, of Anaheim, Calif., was sentenced to 21 months in federal prison, followed by three years of supervised probation, for two counts of mail fraud for his role in a kickback scheme involving counterfeit and diverted prescription drugs. U.S. District Court Judge Howard F. Sachs also ordered Lamoreaux to pay $115,278.54 in restitution to NuCare Pharmaceuticals Inc., the firm that he defrauded. Lamoreaux was convicted of these charges in July 2004.
Todd P. Graves, United States Attorney for the Western District of Missouri, successfully prosecuted Lamoreaux following an investigation conducted by the FDA's Office of Criminal Investigations. Lamoreaux, the former president and CEO of NuCare, defrauded his employer by accepting secret kickbacks for negotiating a contract for the company to purchase counterfeit and diverted prescription drugs from a Missouri pharmaceutical firm and repack these drugs for further sale.
"The FDA's Office of Criminal Investigations and U.S. Attorney's office are to be commended for their work in exposing and pursuing those who deal in drug counterfeiting," says Acting FDA Commissioner Dr. Lester M. Crawford. "Those who attempt to peddle counterfeit drugs endanger lives and the integrity of our country's drug supply. …